BMAL1 and benign neoplasm: Relles et al. found that several CCGs demonstrated decreased expression in PDAC compared to benign tumors or normal pancreas [18], while Li et al. found that low Bmal1 expression (compared to ‘higher expression’) was associated with worse disease-free and overall survival in patients with PDAC [17].